Jieyi Wang

发表

Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells

C. Tse, W. N. Pappano, Qian Zhang, 2014, BMC Cancer.

Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity

Jieyi Wang, Xuanming Yang, Xinyue Qi, 2019, Nature Communications.

Methionine Aminopeptidase 2 Inhibition Is an Effective Treatment Strategy for Neuroblastoma in Preclinical Models

Scott A. Erickson, J. Maris, Jieyi Wang, 2005, Clinical Cancer Research.

Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig

T. Ghayur, Jieyi Wang, Matthew M. Staron, 2017, Protein & Cell.

Safety Evaluation and Whole Genome Sequencing of Aspergillus japonicas PJ01 Reveal Its Potential to Degrade Citrus Segments in Juice Processing

Jieyi Wang, Yang Shan, Gao-yang Li, 2021, Foods.

Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605

S. Davidsen, Eric F. Johnson, N. Soni, 2009, BMC Cancer.

Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration*

Yonghe Li, A. Schwartz, G. Bu, 2002, The Journal of Biological Chemistry.

α‐Synuclein phase separation and amyloid aggregation are modulated by C‐terminal truncations

Jieyi Wang, Shuai Huang, Yinghui Liu, 2022, FEBS letters.

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.

Hyocholic acid species as novel biomarkers for metabolic disorders

Y. Bao, Yike Guo, Cheng Hu, 2021, Nature Communications.

Analyzing the binding of Co(II)-specific inhibitors to the methionyl aminopeptidases from Escherichia coli and Pyrococcus furiosus

Jieyi Wang, G. Sheppard, S. Mitra, 2009, JBIC Journal of Biological Inorganic Chemistry.

Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism

Jieyi Wang, G. Xie, W. Jia, 2022, Frontiers in Pharmacology.

Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.

Scott A. Erickson, S. Davidsen, A. Petros, 2006, Journal of medicinal chemistry.

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking

Jieyi Wang, Mei-Chun Cai, G. Zhuang, 2022, Frontiers in Pharmacology.

Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis

Jieyi Wang, Changbing Shen, Cong Huang, 2022, Frontiers in Genetics.

24‐Dehydrocholesterol reductase promotes the growth of breast cancer stem‐like cells through the Hedgehog pathway

Min Liu, Jieyi Wang, T. Qiu, 2020, Cancer science.

A logic “OR” gate composed of a blue light‐induced CRISPR/dCas9 system and a Tet‐on system activates cancer suppressor genes to inhibit the growth of cutaneous squamous cell carcinoma cells

Jieyi Wang, Xia Wu, Xinbo Huang, 2022, Clinical and Translational Discovery.

Soluble Human Urokinase Receptor Is Composed of Two Active Units*

A. Mazar, J. Henkin, D. Cines, 1997, The Journal of Biological Chemistry.

A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.

Jieyi Wang, A. Zhao, Kun Ge, 2022, Analytical biochemistry.

Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases.

S. Davidsen, Eric F. Johnson, J. Wilsbacher, 2010, Bioorganic & medicinal chemistry letters.

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Xiaoxiao Wang, Jieyi Wang, yang-xin fu, 2016, Cancer cell.

Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor*

S. Futaki, Jieyi Wang, D. Loskutoff, 2002, The Journal of Biological Chemistry.

Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.

D. Egan, Chang H. Park, J. Henkin, 2003, Biochemistry.

Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.

Scott A. Erickson, K. Comess, A. Vasudevan, 2006, Bioorganic & medicinal chemistry letters.

Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR).

S. Davidsen, Eric F. Johnson, J. Wilsbacher, 2007, Bioorganic & medicinal chemistry letters.

3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.

Scott A. Erickson, Jyoti R. Patel, Chang H. Park, 2004, Bioorganic & medicinal chemistry letters.

Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases

J. Henkin, Jieyi Wang, P. Lou, 2000, Journal of cellular biochemistry.

Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids.

Gary T. Wang, Chang H. Park, Jieyi Wang, 2007, Bioorganic & medicinal chemistry letters.

Preparation and characterization of nitrilotriacetic-acid-terminated self-assembled monolayers on gold surfaces for matrix-assisted laser desorption ionization-time of flight-mass spectrometry analysis of proteins and peptides.

Jean M. Severin, Richard D. Smith, Jieyi Wang, 2005, Analytical biochemistry.

1 receptor is relatively resistant to plasminogen activator inhibitor type Single-chain urokinase-type plasminogen activator bound to its

A. Mazar, J. Henkin, D. Cines, 2011 .

ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

Kedar S Vaidya, L. Naumovski, Mark G. Anderson, 2016, Clinical Cancer Research.

Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

X. Liu, J. Wilsbacher, V. Giranda, 2008, Neoplasia.

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Kedar S Vaidya, L. Naumovski, P. Ansell, 2016, BMC Cancer.

PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1

Jieyi Wang, J. Lyu, Haihua Gu, 2020, Oncogene.

Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite*

J. Henkin, Jieyi Wang, V. Nienaber, 2000, The Journal of Biological Chemistry.

Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.

S. Fesik, Qian Zhang, L. Tucker, 2007, Cancer research.

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly

J. Henkin, Jieyi Wang, R. Lesniewski, 2003, Anti-cancer drugs.

Bile Acid–Microbiome Interaction Promotes Gastric Carcinogenesis

Wei Jia, Wenlian Chen, Jieyi Wang, 2022, Advanced science.

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Scott A. Erickson, J. Maris, Chang H. Park, 2003, Cancer research.

Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.

V. Giranda, Yan Luo, Jieyi Wang, 2004, Anticancer research.

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Xiaoxiao Wang, Jieyi Wang, yang-xin fu, 2016, Cancer cell.

Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases.

Scott A. Erickson, S. Davidsen, K. Swinger, 2010, Bioorganic & medicinal chemistry letters.

Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase

Jieyi Wang, E. Reich, 1995, Protein science : a publication of the Protein Society.

Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice

Ping Liu, Cheng Hu, W. Jia, 2022, Nature Communications.

The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention

Li Tao, Jieyi Wang, Mingxian Chen, 2022, Journal of Gastroenterology.

A “Prozone-Like” Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor

Kedar S Vaidya, Mark G. Anderson, W. N. Pappano, 2017, Pharmacology.

USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α

Jieyi Wang, Wei Sun, Haihua Gu, 2021, Cell Death & Disease.

Structure and function of microplasminogen: I. Methionine shuffling, chemical proteolysis, and proenzyme activation

Jieyi Wang, E. Reich, B. Brdar, 1995, Protein science : a publication of the Protein Society.

Removal of benzohydroxamic acid-metal complexes pollution from beneficiation wastewater by metal-biochar/peroxymonosulfate system: Behaviors investigation and mechanism exploration

H. Zhong, Zhiguo He, Jieyi Wang, 2023, Chemical Engineering Journal.

Citrus Segment Degradation Potential, Enzyme Safety Evaluation, and Whole Genome Sequence of Aspergillus aculeatus Strain ZC-1005

Jieyi Wang, Yang Shan, Gao-yang Li, 2021, Frontiers in Microbiology.

Effects of Different Concentrations of Ganpu Tea on Fecal Microbiota and Short Chain Fatty Acids in Mice

Jieyi Wang, Fuhua Fu, Jia-jing Guo, 2021, Nutrients.

Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig™) Proteins with Unique Activities

T. Ghayur, Jieyi Wang, Xiaoqing Lu, 2014, PloS one.

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Kedar S Vaidya, L. Naumovski, P. Ansell, 2016, BMC Cancer.

Comment on “Association Between Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity”

Jieyi Wang, Mingxian Chen, Jinhan Chen, 2023, Obesity Surgery.

Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation*

S. Davidsen, J. Wilsbacher, Gary T. Wang, 2008, Journal of Biological Chemistry.

Correction: Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade (Cancer Cell (2016) 30(3) (500) (S1535610816300381) (10.1016/j.ccell.2016.02.004))

Xiaoxiao Wang, Jieyi Wang, Y. Zhang, 2016 .

Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis.

Jieyi Wang, Tianlu Chen, Xiaojiao Zheng, 2023, Cell metabolism.

Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.

Scott A. Erickson, S. Davidsen, Eric F. Johnson, 2009, Bioorganic & medicinal chemistry letters.

Clinical features and treatment outcomes of Vibrio vulnificus infection in the coastal city of Ningbo, China

Jieyi Wang, Yijun Mo, X. Weng, 2023, Frontiers in microbiology.

Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.

S. Davidsen, P. Richardson, Qian Zhang, 2008, Journal of proteome research.

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.

Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity

Jieyi Wang, Xuanming Yang, Xinyue Qi, 2019, Nature Communications.

Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment

Shusen Zheng, Jieyi Wang, Wu-hua Zhou, 2023, Hepatology.